Previous close | 0.6217 |
Open | 0.6255 |
Bid | 0.6263 x 3900 |
Ask | 0.6316 x 5600 |
Day's range | 0.6201 - 0.6488 |
52-week range | 0.6100 - 1.6300 |
Volume | |
Avg. volume | 9,464,320 |
Market cap | 312.579M |
Beta (5Y monthly) | 1.85 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4400 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.44 |
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, Clover Health Investments, Corp. (the "Company") has reached an agreement to resolve shareholder derivative actions pending in four jurisdictions. The actions are captioned: (1) Sun v. Garipalli, et al., No. 3:21-cv-0311 (M.D. Tenn.); (2) I
Investors who take an interest in Clover Health Investments, Corp. ( NASDAQ:CLOV ) should definitely note that the...